F072-0752 Screening compound: 4-oxo-3-phenyl-N-[2-(piperidin-1-yl)ethyl]-2-(pyrrolidin-1-yl)-3,4-dihydroquinazoline-7-carboxamide

F072-0752 Screening compound: 4-oxo-3-phenyl-N-[2-(piperidin-1-yl)ethyl]-2-(pyrrolidin-1-yl)-3,4-dihydroquinazoline-7-carboxamide
F072-0752 Screening compound: 4-oxo-3-phenyl-N-[2-(piperidin-1-yl)ethyl]-2-(pyrrolidin-1-yl)-3,4-dihydroquinazoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F072-0752
4-oxo-3-phenyl-N-[2-(piperidin-1-yl)ethyl]-2-(pyrrolidin-1-yl)-3,4-dihydroquinazoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F072-0752

Molecular Formula

C26H31N5O2 (C26 H31 N5 O2)

Compound Name

4-oxo-3-phenyl-N-[2-(piperidin-1-yl)ethyl]-2-(pyrrolidin-1-yl)-3,4-dihydroquinazoline-7-carboxamide

IUPAC name

4-oxo-3-phenyl-N-[2-(piperidin-1-yl)ethyl]-2-(pyrrolidin-1-yl)-34-dihydroquinazoline-7-carboxamide

SMILES

O=C(c(cc1)cc(N=C(N2CCCC2)N2c3ccccc3)c1C2=O)NCCN1CCCCC1

InChI

InChI=1S/C26H31N5O2/c32-24(27-13-18-29-14-5-2-6-15-29)20-11-12-22-23(19-20)28-26(30-16-7-8-17-30)31(25(22)33)21-9-3-1-4-10-21/h1,3-4,9-12,19H,2,5-8,13-18H2,(H,27,32)

InChI Key

AXDBUOVYUMYAMD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27099167

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.553

Distribution Coefficient, logD

1.554

Water Solubility, LogSw

-3.28

Polar Surface Area

56.814

Acid Dissociation Constant (pKa)

12.22

Base Dissociation Constant (pKb)

8.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

F072-0752 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F072-0752 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F072-0752?
Check Price and Availability of F072-0752, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F072-0752 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F072-0752
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F072-0752
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F072-0752 available by request